ICAM1 and neuroblastoma: Our data suggest that increased IFNγ secretion from expanded NK cells can mediate ICAM-1 upregulation and enhanced NK cell conjugate formation in brain tumors and NB, enhancing NK cell activity in adoptive immunotherapy.